Estrogen-progestin replacement and risk of breast cancer

Comment

J A Harvey. JAMA. 2000.

. 2000 Aug 9;284(6):692; author reply 693-4.

No abstract available

Comment on

Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk.
Schairer C, Lubin J, Troisi R, Sturgeon S, Brinton L, Hoover R. Schairer C, et al. JAMA. 2000 Jan 26;283(4):485-91. doi: 10.1001/jama.283.4.485. JAMA. 2000. PMID: 10659874

Estrogen-progestin replacement and risk of breast cancer.
Roca CA, Schmidt PJ, Daly RC, Rubinow DR. Roca CA, et al. JAMA. 2000 Aug 9;284(6):693-4. JAMA. 2000. PMID: 10927770 No abstract available.
Estrogen-progestin replacement and risk of breast cancer.
Glaser AN. Glaser AN. JAMA. 2000 Aug 9;284(6):692; author reply 693-4. JAMA. 2000. PMID: 10927767 No abstract available.
Estrogen-progestin replacement and risk of breast cancer.
Del Priore G, Lee MJ. Del Priore G, et al. JAMA. 2000 Aug 9;284(6):691-2; author reply 693-4. JAMA. 2000. PMID: 10927766 No abstract available.
Hormone replacement therapy and risk of breast cancer: the role of progestins.
Stahlberg C, Pedersen AT, Lynge E, Ottesen B. Stahlberg C, et al. Acta Obstet Gynecol Scand. 2003 Apr;82(4):335-44. Acta Obstet Gynecol Scand. 2003. Corrected and republished in: Acta Obstet Gynecol Scand. 2003 Jul;82(7):335-44. PMID: 12716318 Corrected and republished. Review.
Epidemiologic aspects of exogenous progestagens in relation to their role in pathogenesis of human breast cancer.
van Leeuwen FE. van Leeuwen FE. Acta Endocrinol (Copenh). 1991;125 Suppl 1:13-26. Acta Endocrinol (Copenh). 1991. PMID: 1801500 Review.